Literature DB >> 11872862

Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication.

L Sarner1, A Fakoya.   

Abstract

We report the case histories of two HIV-1 positive women in the third trimester of pregnancy who presented with acute lactic acidosis and acute pancreatitis, respectively. One case was fatal for mother and baby. Both women had been stable on regimens containing stavudine and didanosine for at least 2 years before their acute presentations. We speculate on the differential diagnosis, discuss possible reasons for an increased risk of these presentations in pregnant women taking antiretrovirals, and advocate increased vigilance of these women, particularly in the last trimester.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872862      PMCID: PMC1763698          DOI: 10.1136/sti.78.1.58

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  14 in total

Review 1.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Pharmacokinetics of antiretrovirals in pregnant women.

Authors:  Mark Mirochnick; Edmund Capparelli
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis.

Authors:  Bruce J Kirenga; Duncan M Chanda; Catherine M Muwonge; Getnet Yimer; Francis E Adatu; Philip C Onyebujoh
Journal:  Afr J Infect Dis       Date:  2012

4.  [Nucleoside induced hepatopathy in HIV patients. Diagnostic value of liver biopsy assessment].

Authors:  S Haas; J K Rockstroh; U Spengler; H-P Fischer
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

5.  Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.

Authors:  Vivian Black; Risa M Hoffman; Catherine A Sugar; Priya Menon; Francois Venter; Judith S Currier; Helen Rees
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

6.  Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.

Authors:  Russell B Van Dyke; Lu Wang; Paige L Williams
Journal:  J Infect Dis       Date:  2008-12-01       Impact factor: 5.226

Review 7.  Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

8.  Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

Authors:  Carmen D Zorrilla; Vivian Tamayo-Agrait
Journal:  HIV AIDS (Auckl)       Date:  2009-12-08

9.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663

10.  Women facing HIV. Key question on women with HIV infection: Italian consensus workshop.

Authors:  G Carosi; P Nasta; S Fiore; A Matteelli; R Cauda; E Ferrazzi; E Tamburrini; V Savasi; T Bini; M Ravizza; A Bucceri; F Vichi; R Murri; F Mazzotta; A d'Arminio Monforte
Journal:  Infection       Date:  2009-03-23       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.